Myung-Ju Ahn
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Neoadjuvant Nivolumab, Docetaxel, Cisplatin Therapy Followed by Surgery and Radiation Therapy for Resectable High Grade Salivary Gland Carcinoma (NCT05727410) | Myung-Ju Ahn | 2022-11-15 |
Track Myung-Ju Ahn automatically
Every clearance here is in the API, with alerts when new ones post.